| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2136359 | Leukemia Research | 2016 | 5 Pages |
Abstract
Our findings indicated that an immunohistochemical panel that included MPO, CD68 and CD34 could be used for the detection of blastic, differentiated and immature types of myeloid sarcoma. Changes in novel epigenetic regulators, including the loss of TET2 and gain of 5-hmC, as characteristics of myeloid malignancies may be useful novel markers of myeloid sarcoma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Desheng Xiao, Ying Shi, Chunyan Fu, Jiantao Jia, Yu Pan, Yiqun Jiang, Ling Chen, Shuang Liu, Wen Zhou, Jianhua Zhou, Yongguang Tao,